CN200953023Y - Structure of multi-button handheld blood glucose meter - Google Patents
Structure of multi-button handheld blood glucose meter Download PDFInfo
- Publication number
- CN200953023Y CN200953023Y CN 200620013068 CN200620013068U CN200953023Y CN 200953023 Y CN200953023 Y CN 200953023Y CN 200620013068 CN200620013068 CN 200620013068 CN 200620013068 U CN200620013068 U CN 200620013068U CN 200953023 Y CN200953023 Y CN 200953023Y
- Authority
- CN
- China
- Prior art keywords
- blood glucose
- button
- glucose meter
- palm
- value
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000008280 blood Substances 0.000 title claims abstract description 88
- 210000004369 blood Anatomy 0.000 title claims abstract description 86
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title claims abstract description 82
- 239000008103 glucose Substances 0.000 title claims abstract description 82
- 238000012360 testing method Methods 0.000 claims abstract description 20
- 238000005259 measurement Methods 0.000 claims abstract description 15
- 238000012790 confirmation Methods 0.000 claims description 2
- 238000010586 diagram Methods 0.000 description 14
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 238000000034 method Methods 0.000 description 8
- 238000001514 detection method Methods 0.000 description 5
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 230000005540 biological transmission Effects 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000009471 action Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 201000004569 Blindness Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
Images
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Abstract
Description
技术领域technical field
本实用新型涉及一种血糖仪的结构,特别是涉及一种多按键式掌上型血糖仪的结构。The utility model relates to a structure of a blood glucose meter, in particular to a structure of a multi-button palm type blood glucose meter.
背景技术Background technique
医药科技的进步,使得我们得以预防与治疗特定的疾病,因此现代人比起前人而言,无论是男女的寿命都延长了不少,尤其是科学化的检测方式,可提供疾病患者自行测量,再将所述的检验的数据提供予相关医疗专业人仕参考,因此医疗人员得以快速根据病患情况予以适当地治疗,故造就不少病患的疾病得以痊愈。The advancement of medical technology has enabled us to prevent and treat specific diseases. Therefore, compared with the predecessors, the life expectancy of modern people, both men and women, has been extended a lot. In particular, scientific detection methods can provide disease patients with self-measurement , and then provide the data of the test to the relevant medical professionals for reference, so that the medical personnel can quickly and appropriately treat the patients according to the patient's condition, so many patients' diseases can be cured.
而糖尿病为现代文明病之一,其发病原因是人体内的胰脏无法分泌胰岛素(或是分泌不足),所述的胰岛素是分解血液中的血糖,使其转换成人体所需要的能量,而糖尿病患者无法将血糖做有效分解,再进一步会囤积在体内,因此会引起中风机率增加、心肌梗塞、失明与肾衰竭…等种疾病。因此,糖尿病患者除了定时服用药物,定期回医院接受追踪治疗,更需要密集性监测血糖值,作为用药与饮食控制等,以防止疾病发生相关并发症状。Diabetes is one of the diseases of modern civilization. The cause of the disease is that the pancreas in the human body cannot secrete insulin (or insufficient secretion). Diabetics cannot effectively decompose blood sugar, which will further accumulate in the body, which will lead to increased risk of stroke, myocardial infarction, blindness and kidney failure... and other diseases. Therefore, in addition to taking medication regularly and returning to the hospital for follow-up treatment regularly, diabetic patients also need intensive monitoring of blood sugar levels as medication and diet control to prevent disease-related complications.
关于血液的筛检是对于每个人身体内的潜藏疾病提早做一检测,可针对各种成份进行有关于功能指数的检测,当任何检测指示异常时,即表示个人的身体出了某一些毛病,必须提早预防疾病的发病与早期做一治疗。The screening of blood is an early detection of potential diseases in each person's body. It can detect the functional index of various components. When any test indicates abnormality, it means that there is something wrong with the individual's body. It is necessary to prevent the onset of disease and treat it early.
为了随时追踪糖尿病患者的血糖指数,并确实掌握患者病情控制,目前市售随身掌上型血糖仪可帮助患者测量血糖指数,并可做一追踪记录的工作。但是一般市售随身掌上型血糖仪因为操作按键数目较少(通常按键数目为四个以下),因此必须通过繁复按键操作程序才可达到检测的目的,但是对于使用所述的仪器多为老人或身体已产生不便的患者而言,操作不简便、容易忘记操作程序,甚至操作错误而引起用药的极大问题,因此有待从事此行业者加以研发解决此一问题。In order to track the blood sugar index of diabetic patients at any time and ensure the control of the patient's condition, the portable handheld blood glucose meter currently available in the market can help patients measure the blood sugar index and do a track record. However, the general commercially available portable handheld blood glucose meter has a small number of operation buttons (usually the number of buttons is less than four), so the purpose of detection must be achieved through complicated button operation procedures, but most of the people who use the instrument are elderly or elderly. For patients with physical inconvenience, the operation is not easy, it is easy to forget the operation procedure, and even the operation error causes a great problem of medication, so it needs to be developed by those engaged in this industry to solve this problem.
发明内容Contents of the invention
针对现有技术的不足,本实用新型的目的在于:提供一种多按键式掌上型血糖仪的结构,将血糖仪的按键数量设计在每个按键都可对应一个测试功能,按键数量在七个以上,凭借较多的按键数目以简化操作流程,在使用上具有极佳便利性。Aiming at the deficiencies of the prior art, the purpose of this utility model is to provide a structure of a multi-button handheld blood glucose meter. The number of buttons of the blood glucose meter is designed so that each button can correspond to a test function, and the number of buttons is seven. As mentioned above, the operation process is simplified by virtue of a large number of keys, and it has excellent convenience in use.
为达上述的目的,本实用新型采用的技术方案是:For reaching above-mentioned purpose, the technical scheme that the utility model adopts is:
一种多按键式掌上型血糖仪的结构,可利用一血糖试片插入血糖仪的预设界面中,以进行各种血糖测试功能,其是至少包括有下列按键:A structure of a multi-button handheld blood glucose meter. A blood glucose test strip can be inserted into the preset interface of the blood glucose meter to perform various blood glucose testing functions. It at least includes the following buttons:
至少一电源按键,用以开启与关闭血糖仪的电源;at least one power button for turning on and off the power of the blood glucose meter;
至少一调整按键,用以调整/切换血糖仪功能选项的数值;at least one adjustment button for adjusting/switching the value of the function options of the blood glucose meter;
一时间调整按键,用以调整血糖仪的时间,并利用所述的调整按键进行时间变更;A time adjustment button is used to adjust the time of the blood glucose meter, and use the adjustment button to change the time;
一查询记录按键,用以查询旧有的测量记录;以及a query record button, used to query the old measurement records; and
一测量单位切换按键,用以切换显示数值的测量单位。A measurement unit switch button, used to switch the measurement unit of the displayed value.
较佳者,所述的多按键式掌上型血糖仪更是包括有复数个数字输入按键,以分别输入0至9的数字。Preferably, the multi-button handheld blood glucose meter further includes a plurality of number input buttons for inputting numbers from 0 to 9 respectively.
较佳者,所述的多按键式掌上型血糖仪更是包括有一确认按键,用以确认选项的执行。Preferably, the multi-button handheld blood glucose meter further includes a confirmation button for confirming the execution of the option.
较佳者,所述的电源按键的较佳实施例分为二个,一个可控制血糖仪电源开启动作;另一个可控制血糖仪电源关闭动作。Preferably, the preferred embodiment of the power button is divided into two, one can control the action of turning on the power of the blood glucose meter; the other can control the action of turning off the power of the blood glucose meter.
较佳者,所述的调整按键的最佳实施结构分为二个,一个可调整血糖仪功能选项的数值递增;另一个可调整血糖仪功能选项的数值递减。Preferably, the optimal implementation structure of the adjustment button is divided into two, one can adjust the value of the function option of the blood glucose meter to increase; the other can adjust the value of the function option of the blood glucose meter to decrease.
采用上述技术方案的本实用新型具有的优点是:按键数据较多,操作流程简化,使用更方便。The utility model adopting the above-mentioned technical solution has the advantages of more key data, simplified operation process and more convenient use.
附图说明Description of drawings
图1为本实用新型多按键掌上型血糖仪的第一实施结构示意图;Fig. 1 is a schematic diagram of the first implementation of the multi-button handheld blood glucose meter of the present invention;
图2为本实用新型多按键掌上型血糖仪的第二实施结构示意图;Fig. 2 is a schematic diagram of the second implementation structure of the multi-button handheld blood glucose meter of the present invention;
图3为本实用新型多按键掌上型血糖仪的第三实施结构示意图;Fig. 3 is a schematic diagram of the third implementation structure of the multi-button palm-type blood glucose meter of the present invention;
图4为本实用新型多按键掌上型血糖仪的第四实施结构示意图;Fig. 4 is a schematic diagram of the structure of the fourth implementation of the multi-button palm-type blood glucose meter of the present invention;
图5为本实用新型多按键掌上型血糖仪的第五实施结构示意图;Fig. 5 is a schematic diagram of the fifth embodiment of the multi-button handheld blood glucose meter of the present invention;
图6为本实用新型多按键掌上型血糖仪的第六实施结构示意图。Fig. 6 is a schematic structural diagram of the sixth implementation of the multi-button palm-type blood glucose meter of the present invention.
附图标记说明:1-血糖仪;2-血糖试片插入界面;3-显示单元;4-功能按键;41-第一电源按键;42-时间调整按键;43-参数设定按键;44-测量单位切换按键;45-查询记录按键;46-第一调整按键;47-第二调整按键;48-确认按键;49-第二电源按键;5-数字按键;6-数据传输界面。Explanation of reference signs: 1-blood glucose meter; 2-blood glucose test strip insertion interface; 3-display unit; 4-function buttons; 41-first power button; 42-time adjustment button; 43-parameter setting button; 44- Measuring unit switch button; 45-query record button; 46-first adjustment button; 47-second adjustment button; 48-confirm button; 49-second power button; 5-number button; 6-data transmission interface.
具体实施方式Detailed ways
以下以文字配合图式说明本实用新型为达成目的所使用的技术手段与功效,而以下图式所列举的实施例仅为辅助说明,以利贵审委了解,但本案的技术手段并不限于所列举图式。The technical means and effects used by the utility model to achieve the purpose are described below with text and drawings, and the embodiments listed in the following drawings are only auxiliary explanations to facilitate the understanding of your trial committee, but the technical means of this case are not limited to The diagrams listed.
请参阅图1所示,是本实用新型多按键掌上型血糖仪的第一实施结构示意图,其中一血糖仪1在适当处设置有一血糖试片插入界面2,以提供一血糖试片(图中未示)插入检测,而血糖试片上主要的待测物,是为血糖试片上所预置的酵素与病患血液的混合组成,血糖仪1即可凭借所述的待测物的反应结果得到测量数值,而在血糖仪1的适当位置设置有一数据传输界面6,以便于将储存在血糖仪1的血糖测试记录数据,凭借所述的数据传输界面6转换储存在计算机(图中未示)中,有助于作血糖测试记录数据显示与分析,再由专业医疗人员依所述的记录数据与分析结果,施予病患适度的医疗。再在所述的血糖仪1的表面设置有一显示单元3,所述的显示单元3可为一液晶显示器(LCD Display)所构成,因所述的显示单元3所显示内容与现有技术相似,故不在此做一赘述,而显示单元的下方设置有复数个功能按键4,所述的功能按键4的上方可印刷各国文字加以批注功能,以配合不同销售地点的需求,本实施例的功能按键4是为七个按键所组成,其七个按键的个别功能如下:Please refer to Fig. 1, which is a schematic diagram of the first implementation of the multi-button handheld blood glucose meter of the present invention, wherein a
一第一电源按键41,用以开启与关闭血糖仪的电源;A
一时间调整按键42,用以调整血糖仪的时间,并利用所述的调整按键进行时间变更;A
一参数设定按键43,用以设定输入血糖试片上所指定的参数值,所述的参数设定按键43所设定输入血糖试片上的参数值是可调整血糖仪的放大倍率、斜率调整与截距调整,但是前述血糖试片插入界面2也可插置一参数设置片(图中未示),利用所述的参数设置片来直接设定血糖的参数值,此时即可不需使用参数设定按键43来进行参数设定,因此所述的参数设定按键43具有被省略简化的可能性;A
一测量单位切换按键44,用以切换显示数值的测量单位,所述的测量单位切换按键44所可切换测量单位是在mg/dl与mmol/L进行交互切换;A measurement
一查询记录按键45,用以查询旧有测量记录,所述的查询记录按键45可查询的旧有测量记录是为上一笔记录、七日平均记录、十四日平均记录或三十日平均记录等,以便于患者追踪血糖测量数值;A
一第一调整按键46,可调整血糖仪功能选项的数值递增;A
一第二调整按键47,可调整血糖仪功能选项的数值递减。A
请参阅图2所示,是为本实用新型多按键掌上型血糖仪的第二实施结构示意图,其组成结构与图1所揭示的结构相似,其不同处在于其功能按键4增设一确认按键48,用以确认选项的执行。Please refer to FIG. 2, which is a schematic diagram of the second embodiment of the multi-button palm-type blood glucose meter of the present invention. Its composition structure is similar to the structure disclosed in FIG. , to confirm the execution of the option.
请参阅图3所示,是为本实用新型多按键掌上型血糖仪的第三实施结构示意图,其组成结构与图2所揭示的结构相似,其不同处在于其功能按键4增设第二电源按键49,此时前述图式所揭示第一电源按键41的功能单纯只有开启电源的功能,而第二电源按键49即具有关闭电源的功能,而利用第一电源按键41与第二电源按键49的开启与关闭功能分离,而可使操作界面更加地简易。Please refer to FIG. 3 , which is a schematic diagram of the third embodiment of the multi-button handheld blood glucose meter of the present invention. Its composition structure is similar to the structure disclosed in FIG. 2 , and the difference is that a second power button is added to the
请参阅图4所示,是为本实用新型多按键掌上型血糖仪的第四实施结构示意图,其组成结构与图1所揭示的结构相似,其不同处在于在血糖仪中增设了0至9的数字按键5,所述的数字按键5即可有助于输入数字(例如:时间与参数的输入),而可减少使用第一调整按键46与第二调整按键47的频率,同时可达到简化操作的目的。Please refer to Figure 4, which is a schematic diagram of the fourth implementation of the multi-button palm-type blood glucose meter of the present invention. The
请参阅图5所示,是为本实用新型多按键掌上型血糖仪的第五实施结构示意图,其组成结构与图2所揭示的结构相似,其不同处在于在血糖仪中增设了0至9的数字按键5,而较佳处也与图4所提出简化操作的目的相同。Please refer to Figure 5, which is a schematic diagram of the fifth embodiment of the multi-button palm-type blood glucose meter of the present invention. The
请参阅图6所示,是为本实用新型多按键掌上型血糖仪的第六实施结构示意图,其组成结构与图3所揭示的结构相似,其不同处在于在血糖仪中增设了0至9的数字按键5,而较佳处也与图4所提出简化操作的目的相同。Please refer to Fig. 6, which is a schematic diagram of the sixth embodiment of the multi-button palm-type blood glucose meter of the present invention. Its composition structure is similar to that disclosed in Fig. 3. The
凭借上述图1至图6的揭示,即可了解本实用新型的多按键掌上型血糖仪的结构的主要目的在于将血糖仪的按键数量设计至少在七个以上,由于每个按键都可对应一个测试功能,凭借较多的按键数目以简化操作流程,在使用上具有极佳便利性,可解决市售随身型血糖仪因为操作按键数目较少,因此必须透过繁复按键操作程序才可达到检测的缺点,具有极大的市场价值,故提出专利申请以寻求专利权的保护。1 to 6 above, it can be understood that the main purpose of the structure of the multi-button palm-type blood glucose meter of the present invention is to design the number of buttons of the blood glucose meter to be at least seven or more, because each button can correspond to one The test function simplifies the operation process with a large number of buttons, and has excellent convenience in use, which can solve the problem of commercially available portable blood glucose meters. Because the number of operation buttons is small, the detection must be achieved through complicated button operation procedures. The shortcomings of the product have great market value, so a patent application is filed to seek the protection of the patent right.
以上所述,仅为本实用新型的较佳实施例而已,当不能以此限定本实用新型所实施的范围,即大凡依本实用新型权利要求所作的均等变化与修饰,都应仍属于本实用新型专利涵盖的范围内,谨请贵审查委员明鉴,并祈惠准,是所至祷。The above is only a preferred embodiment of the utility model, and should not limit the scope of the utility model implementation with this, that is, all equal changes and modifications made according to the claims of the utility model should still belong to the utility model. Within the scope covered by the utility model patent, I would like to ask your examiner to take note and pray for your permission.
Claims (6)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200620013068 CN200953023Y (en) | 2006-05-09 | 2006-05-09 | Structure of multi-button handheld blood glucose meter |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200620013068 CN200953023Y (en) | 2006-05-09 | 2006-05-09 | Structure of multi-button handheld blood glucose meter |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN200953023Y true CN200953023Y (en) | 2007-09-26 |
Family
ID=38811324
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200620013068 Expired - Fee Related CN200953023Y (en) | 2006-05-09 | 2006-05-09 | Structure of multi-button handheld blood glucose meter |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN200953023Y (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101785701A (en) * | 2009-01-23 | 2010-07-28 | 李秀 | Device and method for processing information, equipment and reagent carrier |
| CN101990673A (en) * | 2008-02-29 | 2011-03-23 | 霍夫曼-拉罗奇有限公司 | Devices and methods for assessing glycemic control |
| CN101703395B (en) * | 2009-11-12 | 2011-07-06 | 北京阳光和讯科技有限公司 | Instrument for measuring blood pressure and blood sugar |
| CN106227987A (en) * | 2007-12-10 | 2016-12-14 | 拜尔健康护理有限责任公司 | For the interface of health measurement and monitoring system |
| CN112129931A (en) * | 2019-06-24 | 2020-12-25 | 深圳迈瑞生物医疗电子股份有限公司 | Sample detection equipment and measurement mode selection method |
-
2006
- 2006-05-09 CN CN 200620013068 patent/CN200953023Y/en not_active Expired - Fee Related
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106227987A (en) * | 2007-12-10 | 2016-12-14 | 拜尔健康护理有限责任公司 | For the interface of health measurement and monitoring system |
| US10548537B2 (en) | 2007-12-10 | 2020-02-04 | Ascensia Diabetes Care Holdings Ag | Interface for a health measurement and monitoring system |
| US11450411B2 (en) | 2007-12-10 | 2022-09-20 | Ascensia Diabetes Care Holdings Ag | Interface for a health measurement and monitoring system |
| CN101990673A (en) * | 2008-02-29 | 2011-03-23 | 霍夫曼-拉罗奇有限公司 | Devices and methods for assessing glycemic control |
| US8834367B2 (en) | 2008-02-29 | 2014-09-16 | Roche Diagnostics Operations, Inc. | Device and method for assessing blood glucose control |
| CN101785701A (en) * | 2009-01-23 | 2010-07-28 | 李秀 | Device and method for processing information, equipment and reagent carrier |
| CN101703395B (en) * | 2009-11-12 | 2011-07-06 | 北京阳光和讯科技有限公司 | Instrument for measuring blood pressure and blood sugar |
| CN112129931A (en) * | 2019-06-24 | 2020-12-25 | 深圳迈瑞生物医疗电子股份有限公司 | Sample detection equipment and measurement mode selection method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Welch et al. | The Problem Areas in Diabetes Scale: an evaluation of its clinical utility | |
| Alfian et al. | Medication adherence contributes to an improved quality of life in type 2 diabetes mellitus patients: a cross-sectional study | |
| Goldstein et al. | Tests of glycemia in diabetes | |
| Critchell et al. | Accuracy of bedside capillary blood glucose measurements in critically ill patients | |
| Weitgasser et al. | Newer portable glucose meters—analytical improvement compared with previous generation devices? | |
| US20140081662A1 (en) | Sensor-Based Informatics Telemedicine Disease Management Solution | |
| US20070060813A1 (en) | Establishing a long-term profile of blood sugar level aiding self-control of the same | |
| Price | Point-of-care testing in diabetes mellitus. | |
| CN103025242B (en) | Guarantee about average before the meal with the mthods, systems and devices of the statistical power of GLPP difference Message Transmission | |
| TW200600060A (en) | Apparatus for the manufacture of medical devices | |
| CN102824180A (en) | Information processing apparatus and user terminal | |
| EP1397068A2 (en) | Blood glucose tracking apparatus and methods | |
| WO2006009199A1 (en) | Blood sugar level management system | |
| WO2011129418A1 (en) | Blood sugar level measurement device, blood sugar level measurement result display method, and blood sugar level measurement result display control program | |
| CN200953023Y (en) | Structure of multi-button handheld blood glucose meter | |
| CN102236011B (en) | Biochemical detection device with magnifier | |
| Dai et al. | Accuracy of the EasyTouch blood glucose self-monitoring system: a study of 516 cases | |
| Tang et al. | Diabetic peripheral neuropathy and glycemia risk index in type 2 diabetes: a cross-sectional study | |
| Al Hayek et al. | Evaluation of glycemia risk index and continuous glucose monitoring-derived metrics in type 1 diabetes: a real-world observational study | |
| Ding et al. | Correlation between salivary developmental endothelial locus-1, interleukin 17 expression level and severity of periodontal disease in patients with type 2 diabetes mellitus | |
| Faber-Wildeboer et al. | Prevalence and risk factors of depression and diabetes-related emotional distress in patients with type 2 diabetes: A cross-sectional study | |
| EP2973087A1 (en) | System and method for quick-access physiological measurement history | |
| KR20140147849A (en) | Positive reinforcement messages to users based on analytics of prior physiological measurements | |
| Guati et al. | Glucose sensors in medicine: overview | |
| Hosseini et al. | Skin lesions in type 2 diabetic patients |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: XUNYING OPTOELECTRONICS CO., LTD. Free format text: FORMER OWNER: LAI JIADE Effective date: 20090605 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20090605 Address after: Postcode of Taiwan, Hsinchu: Patentee after: OK Biotech Co., Ltd. Address before: Postcode of Taiwan, china: Patentee before: Lai Jiade |
|
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070926 Termination date: 20120509 |